A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma

NCT05050097 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

166

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Talquetamab
DRUG: Carfilzomib
DRUG: Daratumumab SC
DRUG: Lenalidomide
DRUG: Pomalidomide

Sponsor

Janssen Research & Development, LLC